Abstract
In an attempt to identify novel ligands for the dopamine transporter, a series of 4-substituted-2-phenylquinazolines were synthesized and evaluated. Among the compounds studied, 4-[(diphenylmethyl)amino]-2-phenylquinazoline (4 g) was identified as a novel partial inhibitor of [(125)I]RTI-55 binding to the dopamine transporter and a partial inhibitor of [(3)H]dopamine uptake.
MeSH terms
-
Biological Transport / drug effects
-
Cocaine / analogs & derivatives*
-
Cocaine / antagonists & inhibitors
-
Cocaine / metabolism
-
Dopamine / metabolism
-
Dopamine Plasma Membrane Transport Proteins
-
Dopamine Uptake Inhibitors / chemical synthesis
-
Dopamine Uptake Inhibitors / chemistry*
-
Dopamine Uptake Inhibitors / pharmacology*
-
Membrane Glycoproteins*
-
Membrane Transport Modulators*
-
Membrane Transport Proteins / antagonists & inhibitors*
-
Membrane Transport Proteins / metabolism
-
Molecular Structure
-
Nerve Tissue Proteins*
-
Protein Binding
-
Quinazolines / chemical synthesis
-
Quinazolines / chemistry*
-
Quinazolines / pharmacology*
-
Structure-Activity Relationship
Substances
-
4-((Diphenylmethyl)amino)-2-phenylquinazoline
-
Dopamine Plasma Membrane Transport Proteins
-
Dopamine Uptake Inhibitors
-
Membrane Glycoproteins
-
Membrane Transport Modulators
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Quinazolines
-
2beta-carbomethoxy-3beta-(4-iodophenyl)tropane
-
Cocaine
-
Dopamine